LOSARTAN POTASSIUM MSD 100 Milligram Film Coated Tablet Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

losartan potassium msd 100 milligram film coated tablet

merck sharp & dohme ireland (human health) limited - losartan potassium - film coated tablet - 100 milligram - angiotensin ii antagonists, plain

LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE LICONSA 100/25 Milligram Film Coated Tablet Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

losartan potassium/hydrochlorothiazide liconsa 100/25 milligram film coated tablet

laboratorios liconsa, s.a. - losartan potassium hydrochlorothiazide - film coated tablet - 100/25 milligram

LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE LICONSA 50/12.5 Milligram Film Coated Tablet Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

losartan potassium/hydrochlorothiazide liconsa 50/12.5 milligram film coated tablet

laboratorios liconsa, s.a. - losartan potassium hydrochlorothiazide - film coated tablet - 50/12.5 milligram

COZAVAN losartan potassium 25 mg film-coated tablet blister pack Australia - Inggris - Department of Health (Therapeutic Goods Administration)

cozavan losartan potassium 25 mg film-coated tablet blister pack

alphapharm pty ltd - losartan potassium, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; hyprolose - hypertension: cozavan is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents (e.g. thiazide diuretics). renal protection in type 2 diabetic patients with proteinuria: cozavan is indicated to delay the progression of renal disease in hypertensive type 2 diabetics with proteinuria, defined as urinary albumin to creatinine ratio greater than or equal to 300mg/g.